Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.5 USD | -1.61% | -14.95% | -41.18% |
06-04 | Pharvaris Highlights Properties of Deucrictibant in Data Presentations at Recent Congresses | CI |
05-09 | Wedbush Adjusts Pharvaris' Price Target to $31 From $35, Maintains Outperform Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.18% | 888M | |
+55.70% | 59.34B | |
+41.08% | 40.24B | |
-5.39% | 39.88B | |
-5.56% | 28.55B | |
+16.46% | 27.26B | |
-20.56% | 19.23B | |
+33.03% | 12.61B | |
+25.85% | 12.28B | |
+2.72% | 12.49B |
- Stock Market
- Equities
- PHVS Stock
- News Pharvaris N.V.
- JMP Securities Starts Pharvaris at Market Outperform With $34 Price Target